Aurionpro Solutions Limited (NSE:AURIONPRO)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	79,243	85,362	52,310	7,000	7,415	3,113
Market Cap Growth	6.61%	63.19%	647.33%	-5.61%	138.21%	238.27%
Enterprise Value	75,982	82,543	52,805	7,568	7,836	4,716
Last Close Price	1475.40	1603.00	1095.09	153.27	161.40	67.76
PE Ratio	41.59	45.85	37.11	7.19	10.49	-
Forward PE	31.80	4.95	4.95	4.95	4.95	4.95
PS Ratio	6.35	7.28	5.89	1.06	1.47	0.83
PB Ratio	5.25	5.66	5.53	1.36	1.84	0.92
P/TBV Ratio	8.71	9.38	9.39	1.84	2.37	1.21
P/FCF Ratio	-	137.89	39.84	-	15.13	7.88
P/OCF Ratio	-	54.34	31.97	17.12	11.95	6.33
PEG Ratio	-	0.25	0.25	0.25	0.25	0.25
EV/Sales Ratio	6.09	7.04	5.95	1.15	1.55	1.26
EV/EBITDA Ratio	29.33	33.57	28.61	5.37	7.41	7.82
EV/EBIT Ratio	33.86	38.25	30.55	5.73	7.96	8.91
EV/FCF Ratio	-	133.34	40.22	-	15.98	11.94
Debt / Equity Ratio	0.02	0.02	0.09	0.17	0.15	0.37
Debt / EBITDA Ratio	0.12	0.12	0.43	0.60	0.55	1.86
Debt / FCF Ratio	-	0.49	0.62	-	1.25	3.14
Asset Turnover	-	0.70	0.79	0.88	0.80	0.47
Inventory Turnover	-	25.72	20.82	19.19	15.43	9.86
Quick Ratio	-	1.78	1.73	1.16	1.61	1.19
Current Ratio	-	2.95	2.20	1.95	2.11	1.90
Return on Equity (ROE)	-	15.35%	19.57%	22.18%	20.34%	-24.23%
Return on Assets (ROA)	-	8.06%	9.62%	11.04%	9.75%	4.16%
Return on Capital (ROIC)	10.93%	10.51%	13.25%	15.46%	13.25%	5.30%
Return on Capital Employed (ROCE)	-	13.70%	17.50%	23.40%	21.80%	13.00%
Earnings Yield	2.45%	2.18%	2.70%	13.91%	9.53%	-39.17%
FCF Yield	-	0.73%	2.51%	-0.72%	6.61%	12.69%
Dividend Yield	0.29%	0.25%	0.11%	0.82%	0.77%	-
Payout Ratio	-	10.09%	4.27%	5.86%	-	-
Buyback Yield / Dilution	-10.71%	-12.46%	-6.12%	-	-	2.54%
Total Shareholder Return	-10.42%	-12.21%	-6.00%	0.82%	0.77%	2.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.